The preparation sustanon cycle consists of sodium citrate (peptizing agent which displaces the bound water contained in the stool), sodium lauryl (dilutes the contents of the intestine) and sorbitol (increases laxative effect by stimulation of water flow to the intestines). Increasing the amount of water and peptization by thinning helps soften the stool and facilitates bowel movements.
Indications for use:
Constipation, including with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
Individual hypersensitivity to the drug.
Pregnancy and lactation:
Adequate and well-controlled studies in pregnant women have been conducted. Since this drug is probably absorbed into the systemic circulation to a minor extent, if it is applied in accordance with the recommendations during pregnancy or lactation is not expected of adverse effects to the fetus or infant.
Dosage and administration:
Adults and children over 3 years
Enter the contents of one microclysters (5 ml), rectally, by inserting the tip of the entire length. Infants sustanon cycle and children up to 3 years Enter the contents of one microclysters rectum by inserting the tip of half the length (cm. Mark on the tip). If complaints persist for a long time, you need to seek medical attention. instructions for use: Break the seal on the tip of the tube. Gently push the tube so that the drop of the drug lubricated tip of the enema – it will facilitate the introduction of the process. in the application of micro-enemas 5 ml for children under 3 -x years enter the enema tip into the rectum to half the length, after 3 years, insert the tip into the rectum an enema as a whole. squeezing a tube, squeeze out the contents completely. Remove the tip, still slightly squeezing the tube.
According spontaneous reports of adverse events
Adverse reactions occurring during treatment with the drug, which have been identified during post-marketing use were classified as follows: very common (≥10%), frequent (≥1%, but <10%), not frequent (≥ 0.1%, but <1%), rare (≥0,01%, but <0.1%), very rare (<0.01%) and adverse reactions with unknown incidence (frequency of occurrence is not can be estimated on the basis of available data). Violations of the gastrointestinal tract . Very rare: abdominal pain (including abdominal discomfort, abdominal pain and upper abdominal); aiorektalnoy discomfort in the area, loose stools. Violations by the immune system . Very rare: hypersensitivity reactions (eg, urticaria).
Interaction with other drugs:
There is the risk of colon necrosis, while oral / rectal sodium polystyrene sulfonate and Sorbitol, which is part of the preparation.
If symptoms persist, avoid prolonged use and consult a doctor.
If the drug became useless or expired shelf life – do not pour it into the waste water and do not throw into the street! Place the drug in the bag and place in the trash. These measures will help protect the environment!
Effects on ability to drive vehicles and management mechanisms:
Sustanon cycle ® does not affect the ability to drive vehicles and management mechanisms.